BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  COVID-19 Vaccines Prove Potency in Real-World Studies

  As the vaccines against COVID-19 are being rolled out worldwide, numerous studies are being conducted to evaluate how the vaccines do under less controlled situations. Here’s a look.

  February 25, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  BMS, bluebird Publish Ide-Cel Data in NEJM, One Month Ahead of PDUFA Date

  Bristol Myers Squibb and bluebird bio said data from the Phase II KarMMa study evaluating the safety and efficacy of ide-cel (idecabtagene vicleucel) met the primary endpoint of overall survival and the key secondary endpoint of complete response rate.

  February 25, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  Feeling Unmotivated? 3 Motivation Tips to Reinvigorate Your Career

  Is your job is slowly starting to make you feel unmotivated or unproductive? Are you unable to work properly? Use these motivation tips to rejuvenate yourself.

  February 25, 2021

   · 

  3 min read

   · 

  Laura Brothers
• 

  Business

  Gene Replacement Therapy-Focused Jaguar and Its Subsidiary Launch with Deerfield-backed Series A

  Deerfield Management-backed Jaguar Gene Therapy, and its ciliopathy-focused subsidiary Axovia Therapeutics, launched today with an undisclosed Series A.

  February 25, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  Vitamin C Study Fails to Improve Sepsis Outcomes

  A new study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.

  February 25, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  FDA

  Humira Bags Another FDA Approval, This Time for Pediatric Ulcerative Colitis

  The U.S. Food and Drug Administration has approved AbbVie’s biologic therapy HUMIRA® (adalimumab) as a treatment for moderate-to-severe active ulcerative colitis in children aged 5 years and older.

  February 25, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Deals

  Merck Snaps Up Autoimmune-Focused Pandion in Massive $1.85 Billion Deal

  Merck said the acquisition adds a pipeline of drug candidates that target a broad range of autoimmune diseases.

  February 25, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Pharma Industry’s Credit Slumps Amidst Pricing Pressures and M&A Activity

  While public perception of the pharmaceutical industry is on an upswing among the general population due to rapid vaccine and therapeutic development during the COVID-19 pandemic, in the eyes of credit rating agencies, the industry is on a continued downward spiral.

  February 25, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Experts Study Use of COVID-19 Vaccine Boosters to Fight Emerging Variants

  As scientists and vaccine manufacturers continue to test their products against the variants, researchers are seeing new variants cropping up that originated in the U.S.

  February 25, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Implement a New Routine Now That You Work from Home

  Establishing boundaries between your personal and professional lives is the key to maintaining fulfilling versions of each.

  February 25, 2021

   · 

  2 min read

   · 

  Laura Brothers